• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Heart Attack Patients Without Standard Risk Factors Face Higher Early Mortality

by
November 12, 2026
in Health
Reading Time: 7 mins read
0
Heart Attack Patients Without Standard Risk Factors Face Higher Early Mortality

Heart Attack Patients Without Standard Risk Factors Face Higher Early Mortality

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Patients suffering an acute ST-segment-elevation myocardial infarction who present without any of the four standard modifiable cardiovascular risk factors experience significantly elevated thirty-day mortality compared to individuals who possess conventional risk profiles, according to a retrospective hospital-based investigation analyzing two distinct international cohorts. The collaborative dual-center study, published in Frontiers in Cardiovascular Medicine, evaluated comprehensive medical records from 6,892 patients treated at the First Hospital of Lanzhou University in China between 2014 and 2023 alongside 4,480 patients documented within the United States Medical Information Mart for Intensive Care IV database between 2008 and 2019. Across both inpatient populations, individuals lacking standard cardiovascular risk factors demonstrated a paradoxical elevation in early post-infarction death rates, accompanied in the intensive care cohort by a heightened susceptibility to acute neurological delirium. These observational findings indicate that clinical risk stratification schemes relying exclusively on conventional risk factor tallies fail to capture substantial residual cardiovascular risk, challenging the long-standing clinical paradigm that assumes a complete absence of established modifiable threats naturally guarantees a comparatively benign disease course and favorable survival outcomes following an occlusive myocardial event.

For decades, contemporary primary and secondary cardiovascular prevention frameworks have concentrated on four standard modifiable cardiovascular risk factors, commonly abbreviated as SMuRFs: hypertension, diabetes mellitus, hyperlipidemia, and tobacco smoking. However, clinical registries increasingly indicate that between ten and twenty-five percent of individuals who experience ST-segment-elevation myocardial infarction present without a single one of these established predisposing elements, designating them as SMuRF-less patients. Under classical epidemiological models derived from historical Framingham calculations, reducing or eliminating standard cardiovascular risk factors directly correlates with superior clinical prognosis and diminished vascular vulnerability. Emerging clinical reports have begun to contradict this intuitive assumption by documenting unexpectedly severe short-term clinical trajectories among patients lacking traditional risk indicators. To resolve ongoing inconsistencies surrounding the clinical trajectory of this population, the research team designed a comprehensive investigation aimed at evaluating short-term thirty-day mortality, intermediate-term survival extending through three hundred and sixty-five days, and acute post-infarction in-hospital complications. Furthermore, the investigators incorporated detailed sequential attenuation analyses and expanded metabolic sensitivity frameworks to explore the clinical and physiological mechanisms that might drive this paradoxical clinical phenomenon across distinct international healthcare environments.

The study cohort assembled from the First Hospital of Lanzhou University was integrated through the China STEMI Care Project and the National Chest Pain Centers Program, identifying consecutive patients who satisfied the Fourth Universal Definition of Myocardial Infarction. In parallel, the American cohort was derived from the intensive care electronic database MIMIC-IV using standardized International Classification of Diseases diagnostic coding for acute transmural infarction. Within both cohorts, SMuRF-less status was defined as the simultaneous absence of documented clinical diagnoses or active treatment for hypertension, diabetes mellitus, hyperlipidemia, and tobacco smoking, with the latter defined as smoking at least one cigarette daily for more than six consecutive months. Hyperlipidemia was ascertained through physician diagnosis, recorded past medical history, or laboratory confirmation of low-density lipoprotein cholesterol exceeding 135 milligrams per deciliter or total cholesterol exceeding 213 milligrams per deciliter. Recognizing that standard risk factor models often overlook excess adiposity, the researchers performed sensitivity analyses incorporating obesity, defined by a body mass index equal to or exceeding 30 kilograms per square meter, as a fifth negative criteria. Within the primary analytical frameworks, SMuRF-less individuals comprised 17.2 percent of the Lanzhou cohort, representing 1,182 patients, and 13.6 percent of the MIMIC-IV population, representing 608 patients.

Comparative analyses revealed striking baseline epidemiological disparities between the Chinese and American cohorts, reflecting distinct underlying demographic and environmental health patterns. In the Lanzhou population, current smoking stood as the dominant standard risk factor, documented in 66.9 percent of patients possessing conventional risks, followed by hypertension at 51.0 percent, diabetes at 22.2 percent, and hyperlipidemia at 20.1 percent. Conversely, the intensive care cohort in the United States displayed an overwhelmingly metabolic risk distribution, characterized by hypertension in 74.2 percent of risk-bearing individuals, hyperlipidemia in 66.8 percent, and diabetes in 46.3 percent, alongside a markedly lower smoking prevalence of 13.2 percent. Within the Lanzhou registry, SMuRF-less patients were significantly older than their risk-bearing counterparts, averaging 62 years compared to 60 years, and included a considerably greater proportion of women, at 24.0 percent versus 12.9 percent, alongside a higher frequency of ethnic minority patients. In contrast, SMuRF-less patients within the MIMIC-IV database were significantly younger than their risk-bearing peers, averaging 66 years versus 72 years, exhibited higher rates of private health insurance coverage, and possessed markedly lower baseline comorbidity burdens, as reflected by a median Charlson comorbidity index score of 4.0 compared to 6.0.

Despite presenting without traditional cardiovascular risk markers, SMuRF-less patients in both cohorts exhibited substantially greater hemodynamic instability and heightened physiological compromise upon hospital admission. Within the Lanzhou cohort, patients lacking conventional risk factors presented with significantly lower mean systolic blood pressure, measuring 120 millimeters of mercury compared to 127 millimeters of mercury in patients with standard risks, alongside more than double the incidence of cardiogenic shock, occurring in 12.2 percent versus 5.3 percent. They also demonstrated higher rates of Killip class IV presentations, reaching 13.8 percent versus 6.7 percent, and suffered a greater proportion of anterior wall infarctions, measured at 53.8 percent versus 50.6 percent. Similarly, SMuRF-less patients in the MIMIC-IV database presented with lower systolic blood pressure, higher admission heart rates averaging 105 beats per minute versus 101 beats per minute, elevated respiratory rates, and significantly higher median creatine kinase-MB concentrations of 36.0 units per liter compared to 22.0 units per liter, indicating greater extent of acute myocardial tissue necrosis. These patients additionally displayed higher systemic white blood cell counts, hemoglobin concentrations, and hematocrit levels, although admission serum creatinine levels were paradoxically lower among SMuRF-less groups in both hospital settings.

Procedural interventions and post-admission clinical management exhibited noticeable divergences between the two patient groups across both medical centers. In the Lanzhou cohort, SMuRF-less individuals were significantly less likely to receive timely primary reperfusion interventions, experiencing higher rates of completely omitted reperfusion therapy at 7.0 percent versus 4.8 percent and higher rates of avoiding any interventional procedures at 7.8 percent versus 5.2 percent. Coronary stent implantation was successfully completed in only 76.1 percent of SMuRF-less patients compared to 84.2 percent of those possessing standard risks, and among those undergoing primary percutaneous coronary intervention, the median time elapsed between initial symptom onset and mechanical device activation was significantly prolonged at 456 minutes compared to 425 minutes. In the American cohort, rates of emergency coronary artery bypass grafting were halved among SMuRF-less individuals, totaling 9.9 percent compared to 19.6 percent, while primary percutaneous intervention rates remained comparable. Strikingly, SMuRF-less patients in both cohorts consistently received lower rates of guideline-directed medical therapies, including oral aspirin, P2Y12 platelet inhibitors, statins, and beta-blockers. Yet, reflecting their profound hemodynamic collapse, SMuRF-less patients required significantly higher deployments of advanced mechanical life support, including intra-aortic balloon pumps, extracorporeal membrane oxygenation, early invasive mechanical ventilation, and intravenous vasopressor infusions.

Survival analyses demonstrated that the mortality penalty associated with lacking conventional cardiovascular risk factors manifested predominantly during the acute in-hospital and early post-discharge phases. In the Lanzhou registry, thirty-day unadjusted mortality reached 10.1 percent among SMuRF-less patients compared to 4.1 percent among patients with standard risks, corresponding to an unadjusted hazard ratio of 2.58. After comprehensive multivariable adjustment controlling for patient demographics, underlying comorbidities, presenting clinical severity, and acute pharmacological and mechanical treatments, SMuRF-less status remained independently associated with increased thirty-day mortality, yielding an adjusted hazard ratio of 1.37. In the MIMIC-IV cohort, thirty-day mortality reached 26.2 percent in the SMuRF-less group compared to 18.8 percent in the standard risk group, maintaining an adjusted hazard ratio of 1.67. Landmark survival evaluations separating the first month from subsequent follow-up indicated that the association weakened over time. In Lanzhou, mortality occurring between days 31 and 365 did not significantly differ between groups after multivariable adjustment, yielding an adjusted hazard ratio of 1.68 with a confidence interval spanning 0.84 to 3.37. However, in the MIMIC-IV cohort, SMuRF-less status retained a statistically significant association with late mortality between days 31 and 365 following multivariable adjustment, recording an adjusted hazard ratio of 1.34.

Beyond mortality outcomes, the researchers evaluated secondary clinical endpoints, revealing divergent complication patterns across the two distinct patient populations. In the Lanzhou cohort, SMuRF-less status was not significantly associated with in-hospital major adverse cardiac and cerebrovascular events, yielding an adjusted odds ratio of 0.93. Individual evaluation of secondary endpoints in China demonstrated no statistically significant differences in the incidence of new-onset heart failure, non-fatal recurrent myocardial infarction, non-fatal stroke, target vessel revascularization, or overall length of hospital stay. In the MIMIC-IV intensive care database, SMuRF-less status was strongly associated with a higher incidence of acute delirium occurring within seven days of admission, recorded in 28.5 percent of SMuRF-less patients compared to 23.3 percent of conventional risk patients, producing a fully adjusted hazard ratio of 1.40. Conversely, the incidence of seven-day acute kidney injury showed no significant association with risk factor status, occurring in 66.3 percent of SMuRF-less patients and 69.6 percent of standard risk individuals, producing an adjusted hazard ratio of 1.05. Competing-risk regressions treating mortality as an active competing event verified these exact patterns for both delirium and renal injury, while multinomial assessments of thirty-day major adverse kidney events confirmed excess mortality without accompanying increases in renal replacement therapy or persistent renal dysfunction.

To unravel the mechanistic pathways driving these clinical associations, investigators conducted sequential attenuation modeling using the deeply phenotyped MIMIC-IV cohort alongside subgroup stratification across both registries. In sequential attenuation evaluations for thirty-day mortality, controlling for patient demographics and baseline comorbidities established a baseline adjusted hazard ratio of 2.10. Introducing metabolic, inflammatory, and hematological variables produced an unexpected 13.1 percent amplification of this association, while accounting for markers of hypoperfusion, myocardial injury, and organ dysfunction caused a negligible 1.0 percent reduction. In contrast, incorporating in-hospital clinical interventions and advanced organ-support measures caused an extensive 41.8 percent reduction in the beta coefficient, pulling the hazard ratio to 1.54. Similarly, adjustment for treatments and life-support therapies attenuated the association between SMuRF-less status and acute delirium by 51.1 percent. In subgroup analyses within the Lanzhou cohort, significant statistical interactions emerged regarding mechanical circulatory support and baseline Killip classification. The excess thirty-day mortality associated with SMuRF-less status was markedly amplified among patients who did not receive extracorporeal membrane oxygenation, those managed without intra-aortic balloon pumps, and individuals presenting with Killip class I to III symptoms rather than overt cardiogenic shock.

The study authors highlighted several methodological strengths and unavoidable limitations that contextualize their observational conclusions. Key strengths include the evaluation of two massive, independent cohorts representing diverse geographic populations, the pioneering inclusion of neurological and renal endpoints, and the validation of findings through sensitivity analyses incorporating obesity. Nevertheless, the retrospective design cannot eliminate unmeasured residual confounding, and relying on electronic health records introduces potential misclassification, such as the underreporting of smoking or unrecorded dyslipidemia in patients who bypassed lipid panels during emergency admissions. Crucial biological markers, including high-sensitivity C-reactive protein, detailed socioeconomic metrics, and polygenic risk scores, were unavailable, leaving deeper biological vulnerabilities unexplored. Ultimately, the investigators concluded that while disparities in guideline-directed therapies and organ-support interventions account for substantial portions of observed risk, they do not fully explain the heightened early mortality and acute delirium characterizing SMuRF-less infarction. These persistent associations suggest that unmeasured genetic predispositions, absent ischemic preconditioning, and heightened biological susceptibility contribute fundamentally to the SMuRF-less paradox, underscoring the urgent necessity for heightened early clinical vigilance when managing myocardial infarction patients who appear deceptively free of conventional cardiovascular threats.

Subject of Research: Early mortality and clinical outcomes among STEMI patients without standard modifiable cardiovascular risk factors

Article Title: The SMuRF-less paradox in ST-segment-elevation myocardial infarction: a retrospective hospital-based two-cohort study

Article References: Zhao, J., Wei, J., Pan, C., Peng, Y., Lei, P., Lian, Q., Lyu, J., Bai, M., & Zhang, Z. (2026). The SMuRF-less paradox in ST-segment-elevation myocardial infarction: a retrospective hospital-based two-cohort study. Frontiers in Cardiovascular Medicine, 13, Article 1955087. https://doi.org/10.3389/fcvm.2026.1955087

Image Credits: AI Generated

DOI: 10.3389/fcvm.2026.1955087

Keywords: cardiology, myocardial infarction, STEMI, cardiovascular risk factors, delirium, clinical outcomes, mortality, critical care, SMuRF-less, paradox, ST-segment-elevation, myocardial

News Source: Ophelia Keating. (November 12, 2026). Heart Attack Patients Without Standard Risk Factors Face Higher Early Mortality. Scienmag.

Tags: CardiologyCardiovascular risk factorsclinical outcomesCritical CaredeliriummortalitymyocardialMyocardial InfarctionparadoxSMuRF-lessST-segment elevationSTEMI
Share12Tweet7Share2ShareShareShare1

Related Posts

Bedside Perfusion Ladder Guides Heart Failure Therapy Beyond Blood Pressure Readings

Bedside Perfusion Ladder Guides Heart Failure Therapy Beyond Blood Pressure Readings

November 18, 2026
Cancer Cells Neutralise Toxic Formaldehyde and Resist Ferroptosis Through Coordinated Defences

Cancer Cells Neutralise Toxic Formaldehyde and Resist Ferroptosis Through Coordinated Defences

November 18, 2026

Dynamic Biomarker Trajectories Link to Kidney Injury in Pregnancy-Related Sepsis

November 18, 2026

Pantothenic Acid Deficiency Outbreak Drives Severe Piglet Mortality and Neuromuscular Disorders

November 18, 2026

POPULAR NEWS

  • Coal Gangue Aggregates Can Replace Natural Stone in Concrete Applications

    Coal Gangue Aggregates Can Replace Natural Stone in Concrete Applications

    29 shares
    Share 12 Tweet 7
  • Cluster-Based Training Selection Outperforms Active Learning for Material Property Prediction

    29 shares
    Share 12 Tweet 7
  • Cesarean Section Rates Reached Forty Percent Among Surveyed Mothers in Njombe Region

    29 shares
    Share 12 Tweet 7
  • Testosterone Injections Exacerbate Pre-Neoplastic Prostate Lesions in NKX3.1-Deficient Mice

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Japanese Abalone Subspecies Show Deep Genomic Divergence Shaped by Marine Environments

Urolithin A Combats Diabetic Kidney Disease by Inhibiting Cellular Ferroptosis

Bedside Perfusion Ladder Guides Heart Failure Therapy Beyond Blood Pressure Readings

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.